Hematopoietic stem cell transplants for chronic myeloid leukemia in Europe—Impact of cost considerations

This publication has 22 references indexed in Scilit:

• Hematopoietic Stem-Cell Transplantation
  New England Journal of Medicine, 2006
• Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe
  Bone Marrow Transplantation, 2006
• Chronic myeloproliferative disorders: a tyrosine kinase tale
  Leukemia, 2005
• The early referral for reduced-intensity stem cell transplantation in patients with Ph1 (+) chronic myelogenous leukemia in chronic phase in the imatinib era: results of the Latin American Cooperative Oncohematology Group (LACOHG) prospective, multicenter study
  Bone Marrow Transplantation, 2005
• Blood and marrow transplantation compensation: Perspective in payer and provider relations
  Transplantation and Cellular Therapy, 2004
• Hematopoietic stem cell transplantation for hematological malignancies in Europe
  Leukemia, 2003
• Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
  New England Journal of Medicine, 2003
• Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe
  British Journal of Haematology, 2002
• Chronic Myeloid Leukemia
  New England Journal of Medicine, 1999
• Transplanted Technology: Third World Options and First World Science
  New England Journal of Medicine, 1987